Sheng Ze Lin - Net Worth and Insider Trading
Sheng Ze Lin Net Worth
The estimated net worth of Sheng Ze Lin is at least $2.8 Billion dollars as of 2024-06-22. Sheng Ze Lin is the Directors, senior managers, core technical personn of Suzhou Zelgen Biopharmaceuticals Co Ltd and owns about 49,910,527 shares of Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) stock worth over $2.8 Billion. Details can be seen in Sheng Ze Lin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sheng Ze Lin has not made any transactions after 2022-05-24 and currently still holds the listed stock(s).
Transaction Summary of Sheng Ze Lin
Sheng Ze Lin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sheng Ze Lin owns 1 companies in total, including Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) .
Click here to see the complete history of Sheng Ze Lin’s form 4 insider trades.
Insider Ownership Summary of Sheng Ze Lin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:688266 | Suzhou Zelgen Biopharmaceuticals Co Ltd | 2022-05-24 | Directors & senior managers & core technical personn |
Sheng Ze Lin Latest Holdings Summary
Sheng Ze Lin currently owns a total of 1 stock. Sheng Ze Lin owns 49,910,527 shares of Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) as of May 24, 2022, with a value of $2.8 Billion.
Latest Holdings of Sheng Ze Lin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:688266 | Suzhou Zelgen Biopharmaceuticals Co Ltd | 2022-05-24 | 49,910,527 | 56.00 | 2,794,989,512 |
Holding Weightings of Sheng Ze Lin
Sheng Ze Lin Form 4 Trading Tracker
According to the SEC Form 4 filings, Sheng Ze Lin has made a total of 7 transactions in Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Suzhou Zelgen Biopharmaceuticals Co Ltd is the acquisition of 920 shares on May 24, 2022, which cost Sheng Ze Lin around $25,024.
Insider Trading History of Sheng Ze Lin
- 1
Sheng Ze Lin Trading Performance
GuruFocus tracks the stock performance after each of Sheng Ze Lin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sheng Ze Lin is -0.63%. GuruFocus also compares Sheng Ze Lin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sheng Ze Lin within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sheng Ze Lin's insider trading performs compared to the benchmark.
Performance of Sheng Ze Lin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.79 | | | | | |
| Relative Return to S&P 500(%) | -7.45 | | | | | |
Sheng Ze Lin Ownership Network
Sheng Ze Lin Owned Company Details
What does Suzhou Zelgen Biopharmaceuticals Co Ltd do?
Who are the key executives at Suzhou Zelgen Biopharmaceuticals Co Ltd?
Sheng Ze Lin is the Directors & senior managers & core technical personn of Suzhou Zelgen Biopharmaceuticals Co Ltd. Other key executives at Suzhou Zelgen Biopharmaceuticals Co Ltd include Core technical personnel zhang bin , senior management Huang Gang , and Directors & senior managers & core technical personn Lv Bin Hua .
Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) Insider Trades Summary
Over the past 18 months, Sheng Ze Lin made no insider transaction in Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266). Other recent insider transactions involving Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) include a net sale of 3,870 shares made by zhang bin , a net sale of 0 shares made by Zhang Jun Li , and a net sale of 0 shares made by Lv Bin Hua .
In summary, during the past 3 months, insiders sold 3,870 shares of Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) in total and bought 0 shares, with a net sale of 3,870 shares. During the past 18 months, 3,870 shares of Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,870 shares.
Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266)'s detailed insider trading history can be found in Insider Trading Tracker table.
Suzhou Zelgen Biopharmaceuticals Co Ltd Insider Transactions
Sheng Ze Lin Mailing Address
Above is the net worth, insider trading, and ownership report for Sheng Ze Lin. Currently GuruFocus does not have mailing address information for Sheng Ze Lin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
